DE BARTOLOMEIS, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3.258
EU - Europa 1.837
AS - Asia 1.709
AF - Africa 99
SA - Sud America 18
OC - Oceania 1
Totale 6.922
Nazione #
US - Stati Uniti d'America 3.185
IT - Italia 857
SG - Singapore 718
HK - Hong Kong 494
CN - Cina 434
FI - Finlandia 160
IE - Irlanda 148
UA - Ucraina 140
DE - Germania 124
NL - Olanda 119
CI - Costa d'Avorio 96
RU - Federazione Russa 90
CA - Canada 69
SE - Svezia 69
GB - Regno Unito 65
VN - Vietnam 24
FR - Francia 16
BR - Brasile 12
IS - Islanda 8
JP - Giappone 7
BD - Bangladesh 6
BG - Bulgaria 6
ES - Italia 6
IN - India 6
BE - Belgio 5
CL - Cile 5
PK - Pakistan 5
HU - Ungheria 4
PL - Polonia 4
AT - Austria 3
GR - Grecia 3
IR - Iran 3
LT - Lituania 3
MX - Messico 3
SI - Slovenia 3
TR - Turchia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
ID - Indonesia 2
NG - Nigeria 2
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 6.922
Città #
Singapore 573
Hong Kong 494
Chandler 443
Santa Clara 292
Millbury 204
Jacksonville 172
Naples 153
Princeton 145
Ashburn 137
Nanjing 114
Beijing 109
Amsterdam 97
Wilmington 88
Norwalk 78
Boston 77
Des Moines 75
Houston 72
Ottawa 58
Seattle 57
Napoli 56
Nanchang 45
Rome 42
Woodbridge 41
Lawrence 34
Milan 29
Shenyang 28
Hebei 27
Dong Ket 24
Jiaxing 23
Falls Church 20
Kronberg 20
Helsinki 19
Changsha 18
Moscow 13
Nuremberg 13
Boardman 12
Dublin 12
Catania 11
Tianjin 10
Kunming 9
Redwood City 9
Aversa 8
Cambridge 8
Ortona 8
Atlanta 7
Fairfield 7
Falkenstein 7
Lappeenranta 7
Paris 7
Portici 7
Reykjavík 7
Turin 7
Cagliari 6
Council Bluffs 6
Guangzhou 6
Monza 6
Toronto 6
Brooklyn 5
Casoria 5
Concordia Sagittaria 5
Gallipoli 5
Genoa 5
Genova 5
Indiana 5
London 5
Los Angeles 5
New York 5
Orange 5
Padova 5
Palermo 5
Salerno 5
Tulsa 5
Avellino 4
Bari 4
Brussels 4
Florence 4
Hangzhou 4
Munich 4
Münster 4
Perugia 4
Santiago 4
Somma Vesuviana 4
Ann Arbor 3
Athens 3
Caivano 3
Cologne 3
Costa di Mezzate 3
Eindhoven 3
Fisciano 3
Foligno 3
Formia 3
Hanover 3
Negishi 3
Nola 3
Pagani 3
Pescara 3
Rawalpindi 3
Richmond 3
Shanghai 3
Southend 3
Totale 4.232
Nome #
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 76
null 75
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 68
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 64
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 63
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 62
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 62
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 61
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 61
Transcranial direct current stimulation for obsessive–compulsive disorder: A randomized, controlled, partial crossover trial 60
Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. 58
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. 57
Cognitive correlates of borderline intellectual functioning in borderline personality disorder 54
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice 53
The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment 51
Dopaminergic regulation of epileptic activity. 51
L'Araba Fenice delle psicosi: rinascita e trasformazione dell'ipotesi dopaminergica 51
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 51
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation 50
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 50
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 50
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 50
Acute administration of antipsychotics modulates Homer striatal gene expression differentially 49
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 49
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 48
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 48
Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis 48
Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain. 47
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 47
A Homer 1 gene variant influences brain structure and function, lithium effects on white matter, and antidepressant response in bipolar disorder: A multimodal genetic imaging study 47
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 47
Neurobiological correlates of anxiety treatment.(Le basi neurobiologiche della terapia dell’ansia) 46
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 46
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 46
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. 45
Antypsychotic induced gene expression in the rat brain: a computational and experimental approach 45
Meccanismi convergenti e divergenti nel dolore e nella depressione 45
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 45
Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia 45
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 45
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 45
Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus. 44
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 44
d-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice 44
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder 44
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 44
Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies. 43
Acute administration of antipsychotics modulates Homer striatal gene expression differentially. 43
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 43
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 43
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 43
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 43
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine 42
Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. 42
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 42
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 42
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 42
Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. 41
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 41
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 41
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 41
Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors 41
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 41
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 40
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 40
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 40
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 40
Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder 40
Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain 39
Fisiopatologia cellulare e molecolare 39
Antipsychotics with different D2 dopamine receptor potency affect differently the postsynaptic density protein homer at glutamatergic metabotropic synapse 39
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia. 39
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 38
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 38
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 38
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice. 37
Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologies. 37
Disturbo da uso di alcol 37
The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. 36
Opioidergic and dopaminergic gene expression in the caudate-putamen and accumbens of the mutant mouse, tottering (tg/tg). 36
Dandy-Walker Syndrome with psychotic symptoms: A case report 36
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 36
The Psychiatric Neuromodulation Unit: Implementation and Management 36
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 36
Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study 35
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 35
Augmentation therapy of antipsychotics by no conventional drugs in schizophrenia treatment 35
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 35
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 35
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 35
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 35
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 35
Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis 34
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 34
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 34
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins 34
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 34
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 33
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 33
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine. 33
Totale 4.441
Categoria #
all - tutte 36.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020231 0 0 0 0 0 0 12 5 4 63 86 61
2020/2021515 35 30 60 42 43 97 44 3 76 21 36 28
2021/2022971 14 1 8 11 8 48 22 32 162 79 163 423
2022/20231.187 193 95 35 49 138 160 14 108 159 103 89 44
2023/20241.016 33 146 92 92 59 51 60 161 35 26 168 93
2024/20252.003 322 423 16 55 170 325 692 0 0 0 0 0
Totale 7.268